Publication | Closed Access
A combination of AT-527, a pan-genotypic guanosine nucleotide prodrug, and daclatasvir was well-tolerated and effective in HCV-infected subjects
11
Citations
0
References
2020
Year
Pan-genotypic GuanosineHcv-infected SubjectsMedicineAntiviral TherapyHepatitisVirologyAntiviral DrugPharmacologyAntiviral CompoundClinical Microbiology
No additional data available for this publication yet. Check back later!